Elixir Pharmaceuticals, Inc. S-1/A
S-1/A · Elixir Pharmaceuticals, Inc. · Filed Jan 7, 2008
Documents
- S-1
AMENDMENT #5 TO FORM S-1
- EX-1.1
UNDERWRITING AGREEMENT
- EX-10.38
LICENSE AGREEMENT WITH BRISTOL-MYERS SQUIBB COMPANY
- EX-10.39
EXCLUSIVE LICENSE AGREEMENT ON MITIGLINIDE WITH KISSEI PHARMACEUTICAL CO. LTD
- EX-10.41
BINDING AGREEMENT BETWEEN NOVARTIS INTERNATIONAL PHARMACEUTICALS AND ELIXIR PHAR
- EX-23.1
CONSENT OF ERNST & YOUNG LLP
- GRAPHICg21963image001.jpg
GRAPHIC